Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07058064 · ClinicalTrials.gov registry record · NA
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
A NA study of Lymphoma and Sarcoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT07058064: Recruiting NA study of Lymphoma and Sarcoma, sponsored by Mayo Clinic.
NCT07058064 is a NA study of Lymphoma and Sarcoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 250 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07058064, a NA study of Lymphoma and Sarcoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find a cost effective cardiovascular (CV) surveillance of cancer survivors over long periods of time to prevent the risk of progression of heart failure (HF) and related morbidity and mortality. Mobile device-based artificial intelligence (AI)-electrocardiogram (ECG) can reliably detect cardiac dysfunction in lymphoma and sarcoma survivors and smart watch based surveillance for cardiotoxicity is feasible and reliable.
Primary Outcome
Mobile device ECGs will be compared to standard 12-lead clinic ECGs for the AI algorithm to predict a reduced EF (EF \<50%).
Interventions
- PROCEDURE Electrocardiogram
- PROCEDURE Echocardiogram
- PROCEDURE LVEF echocardiogram
- OTHER Apple Watch
- PROCEDURE Biospecimen collection
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-07-18 |
| Est. Completion | 2029-06-29 |
| Phase | NA |
What NCT07058064 shows while recruiting
NCT07058064 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (48% lower).
The record links to 2 conditions, with Lymphoma appearing as the primary indexed condition, and to 5 interventions - of which Electrocardiogram is the first listed.
NCT07058064 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07058064 about?
NCT07058064 is a clinical study titled "WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)". The purpose of this study is to find a cost effective cardiovascular (CV) surveillance of cancer survivors over long periods of time to prevent the risk of progression of heart failure (HF) and related morbidity and mortality. Mobile device-based artificial intelligence (AI)-electrocardiogram (ECG) ...
What is the current status of trial NCT07058064?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-07-18. Estimated completion is 2029-06-29.
What conditions does trial NCT07058064 study?
This clinical trial studies the following conditions: Lymphoma, Sarcoma.
What interventions are being tested in trial NCT07058064?
The interventions under investigation include: Electrocardiogram (PROCEDURE), Echocardiogram (PROCEDURE), LVEF echocardiogram (PROCEDURE), Apple Watch (OTHER), Biospecimen collection (PROCEDURE).
Who is sponsoring clinical trial NCT07058064?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07058064 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07058064's enrollment target sits among peer trials
250 43rd of 299 higher than 256 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
-
UPLYFT For Lymphoma Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI